Research interests include biomarkers to enhance disease characterization and development of new therapies, application of genetic testing to improve clinical trial outcomes, and the role of genetics in chronic renal disease. Dr. Bleavins is also interested in assessing immunotoxicity and inflammatory disease as well as three dimensional cell culture approaches for bone marrow and tumor modeling.